Kobo Biotech Limited announced earnings results for the third quarter ended December 31, 2020. For the third quarter, the company announced net loss was INR 57.435 million compared to INR 57.449 million a year ago. Basic loss per share from continuing operations was INR 2.41 compared to INR 2.41 a year ago. For the nine months, total revenue was INR 0.359 million compared to INR 0.344 million a year ago. Net loss was INR 170.43 million compared to INR 172.105 million a year ago. Basic loss per share from continuing operations was INR 7.15 compared to INR 7.22 a year ago.